Literature DB >> 32935808

Effect of COVID-19 on platelet count and its indices.

Ertuğrul Güçlü1, Havva Kocayiğit2, Hüseyin Doğuş Okan1, Unal Erkorkmaz3, Yusuf Yürümez4, Selcuk Yaylacı5, Mehmet Koroglu6, Cem Uzun1, Oğuz Karabay1.   

Abstract

BACKGROUND: Easily accessible, inexpensive, and widely used laboratory tests that demonstrate the severity of COVID-19 are important. Therefore, in this study, we aimed to investigate the relationship between mortality in COVID-19 and platelet count, Mean Platelet Volume (MPV), and platelet distribution width.
METHODS: In total, 215 COVID-19 patients were included in this study. The patients were divided into two groups. Patients with room air oxygen saturation < 90% were considered as severe COVID-19, and patients with ≥90% were considered moderate COVID-19. Patient medical records and the electronic patient data monitoring system were examined retrospectively. Analyses were performed using the SPSS statistical software. A p-value <0.05 was considered significant.
RESULTS: The patients' mean age was 64,32 ± 16,07 years. According to oxygen saturation, 81 patients had moderate and 134 had severe COVID-19. Our findings revealed that oxygen saturation at admission and the MPV difference between the first and third days of hospitalization were significant parameters in COVID-19 patients for predicting mortality. While mortality was 8.4 times higher in patients who had oxygen saturation under 90 % at hospital admission, 1 unit increase in MPV increased mortality 1.76 times.
CONCLUSION: In addition to the lung capacity of patients, the mean platelet volume may be used as an auxiliary test in predicting the mortality in COVID-19 patients.

Entities:  

Mesh:

Year:  2020        PMID: 32935808     DOI: 10.1590/1806-9282.66.8.1122

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  10 in total

1.  Baseline Thrombocytopenia and Disease Severity Among COVID-19 Patients, Tibebe Ghion Specialized Hospital COVID-19 Treatment Center, Northwest Ethiopia.

Authors:  Fikir Asrie; Esayas Tekle; Yemataw Gelaw; Mulat Dagnew; Aschalew Gelaw; Markos Negash; Eyuel Kassa; Segenet Bizuneh; Dessalew Wudineh
Journal:  J Blood Med       Date:  2022-06-10

2.  Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients.

Authors:  Minoosh Moghimi; Manijeh Jozpanahi; Kasra Khodadadi; Seyede Pegah Saeed; Seyede Vanoushe Azimi Pirsaraie; Nooshin Jalili
Journal:  Eur J Transl Myol       Date:  2022-06-20

3.  Using bi-dimensional representations to understand patterns in COVID-19 blood exam data.

Authors:  Vitor P Bezzan; Cleber D Rocco
Journal:  Inform Med Unlocked       Date:  2021-12-30

4.  MPR and NLR as Prognostic Markers in ICU-Admitted Patients with COVID-19 in Jazan, Saudi Arabia.

Authors:  Abdullah A Mobarki; Gasim Dobie; Muhammad Saboor; Aymen M Madkhali; Mohammad S Akhter; Ali Hakamy; Adel Humran; Yousof Hamali; Denise E Jackson; Hassan A Hamali
Journal:  Infect Drug Resist       Date:  2021-11-23       Impact factor: 4.003

5.  Relationship of platelet counts, platelet volumes, and Curb-65 scores in the prognosis of COVID-19 patients.

Authors:  Yeşim Işler; Halil Kaya
Journal:  Am J Emerg Med       Date:  2021-11-09       Impact factor: 4.093

6.  Diagnostic value of platelet indices in COVID 19 infection: a case-control study from a single tertiary care center.

Authors:  Arundhathi Shankaralingappa; Santosh Tummidi; Thirunavukkarasu Arun Babu
Journal:  Egypt J Intern Med       Date:  2022-04-01

7.  Thyroid hormones and platelet activation in COVID-19 patients.

Authors:  O Gandini; C Lubrano; E Colonnello; A Criniti; E Lorusso; M Curreli; M Santulli; A Angeloni; L Gnessi
Journal:  J Endocrinol Invest       Date:  2022-09-05       Impact factor: 5.467

8.  Demographic, clinical, and laboratory features of COVID-19 in children: The role of mean platelet volume in predicting hospitalization and severity.

Authors:  Gizem Guner Ozenen; Zumrut Sahbudak Bal; Zuhal Umit; Nimet Melis Bilen; Sema Yildirim Arslan; Ali Yurtseven; Eylem Ulas Saz; Barutcuoglu Burcu; Ruchan Sertoz; Zafer Kurugol; Ferda Ozkinay
Journal:  J Med Virol       Date:  2021-03-11       Impact factor: 20.693

9.  Predicting acute respiratory distress syndrome in influenza pneumonia patients using delta mean platelet volume.

Authors:  Teeraphat Reangvilaikul; Piyaphat Udompongpaiboon; Veerapong Vattanavanit
Journal:  BMC Pulm Med       Date:  2021-12-07       Impact factor: 3.317

10.  Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes.

Authors:  Gorka Lasso; Saad Khan; Stephanie A Allen; Margarette Mariano; Catalina Florez; Erika P Orner; Jose A Quiroz; Gregory Quevedo; Aldo Massimi; Aditi Hegde; Ariel S Wirchnianski; Robert H Bortz; Ryan J Malonis; George I Georgiev; Karen Tong; Natalia G Herrera; Nicholas C Morano; Scott J Garforth; Avinash Malaviya; Ahmed Khokhar; Ethan Laudermilch; M Eugenia Dieterle; J Maximilian Fels; Denise Haslwanter; Rohit K Jangra; Jason Barnhill; Steven C Almo; Kartik Chandran; Jonathan R Lai; Libusha Kelly; Johanna P Daily; Olivia Vergnolle
Journal:  PLoS Comput Biol       Date:  2022-01-18       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.